Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Neuroprotective effects of the andrographolide analogue AL-1 in the MPP⁺/MPTP-induced Parkinson's disease model in vitro and in mice.

Zhang Z, Lai D, Wang L, Yu P, Zhu L, Guo B, Xu L, Zhou L, Sun Y, Lee SM, Wang Y.

Pharmacol Biochem Behav. 2014 Jul;122:191-202. doi: 10.1016/j.pbb.2014.03.028. Epub 2014 Apr 12.

PMID:
24726706
[PubMed - in process]
2.

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14669-74. Epub 2001 Nov 27.

PMID:
11724929
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

L'Episcopo F, Tirolo C, Caniglia S, Testa N, Serra PA, Impagnatiello F, Morale MC, Marchetti B.

J Neuroinflammation. 2010 Nov 23;7:83. doi: 10.1186/1742-2094-7-83.

PMID:
21092260
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro.

Lee DH, Kim CS, Lee YJ.

Food Chem Toxicol. 2011 Jan;49(1):271-80. doi: 10.1016/j.fct.2010.10.029. Epub 2010 Nov 5.

PMID:
21056612
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Fucoidan protects against dopaminergic neuron death in vivo and in vitro.

Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, Wang X.

Eur J Pharmacol. 2009 Sep 1;617(1-3):33-40. doi: 10.1016/j.ejphar.2009.06.015. Epub 2009 Jun 21.

PMID:
19545563
[PubMed - indexed for MEDLINE]
6.

Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.

Yokoyama H, Takagi S, Watanabe Y, Kato H, Araki T.

J Neural Transm. 2008 Jun;115(6):831-42. doi: 10.1007/s00702-008-0019-6. Epub 2008 Jan 31.

PMID:
18235988
[PubMed - indexed for MEDLINE]
7.
8.

Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.

Schmidt N, Ferger B.

Synapse. 2001 Apr;40(1):47-54.

PMID:
11170221
[PubMed - indexed for MEDLINE]
9.

Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.

Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH.

J Neurochem. 2006 May;97(3):675-86. Epub 2006 Mar 29.

PMID:
16573658
[PubMed - indexed for MEDLINE]
10.

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.

Watanabe Y, Kato H, Araki T.

Metab Brain Dis. 2008 Mar;23(1):51-69. Epub 2007 Nov 21.

PMID:
18030609
[PubMed - indexed for MEDLINE]
11.

Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.

Ghosh A, Kanthasamy A, Joseph J, Anantharam V, Srivastava P, Dranka BP, Kalyanaraman B, Kanthasamy AG.

J Neuroinflammation. 2012 Oct 23;9:241. doi: 10.1186/1742-2094-9-241.

PMID:
23092448
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.

Singh S, Singh K, Patel DK, Singh C, Nath C, Singh VK, Singh RK, Singh MP.

Rejuvenation Res. 2009 Jun;12(3):185-97. doi: 10.1089/rej.2009.0850.

PMID:
19594327
[PubMed - indexed for MEDLINE]
13.

Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In Vivo.

Lo YC, Shih YT, Tseng YT, Hsu HT.

Evid Based Complement Alternat Med. 2012;2012:501032. doi: 10.1155/2012/501032. Epub 2012 Mar 5.

PMID:
22474505
[PubMed]
Free PMC Article
14.

Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease.

Zhang D, Anantharam V, Kanthasamy A, Kanthasamy AG.

J Pharmacol Exp Ther. 2007 Sep;322(3):913-22. Epub 2007 Jun 12.

PMID:
17565007
[PubMed - indexed for MEDLINE]
Free Article
15.

Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.

Teismann P, Ferger B.

Synapse. 2001 Feb;39(2):167-74.

PMID:
11180504
[PubMed - indexed for MEDLINE]
16.

Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.

Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Kim S, Lee D, Chung H, Oh MS, Lee KT, Park S.

Neurotox Res. 2009 May;15(4):332-47. doi: 10.1007/s12640-009-9037-x. Epub 2009 Mar 17.

PMID:
19384567
[PubMed - indexed for MEDLINE]
17.

Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.

Zhai A, Zhu X, Wang X, Chen R, Wang H.

Eur J Pharmacol. 2013 Aug 5;713(1-3):58-67. doi: 10.1016/j.ejphar.2013.04.029. Epub 2013 May 9.

PMID:
23665112
[PubMed - indexed for MEDLINE]
18.

Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.

Zhang L, Huang L, Chen L, Hao D, Chen J.

Toxicol Lett. 2013 Oct 24;222(2):155-63. doi: 10.1016/j.toxlet.2013.07.020. Epub 2013 Aug 1.

PMID:
23911879
[PubMed - indexed for MEDLINE]
19.

Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.

Pérez-H J, Carrillo-S C, García E, Ruiz-Mar G, Pérez-Tamayo R, Chavarría A.

Toxicology. 2014 May 7;319:38-43. doi: 10.1016/j.tox.2014.02.009. Epub 2014 Mar 4.

PMID:
24607817
[PubMed - indexed for MEDLINE]
20.

EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.

Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO.

Eur J Neurosci. 2008 Jul;28(1):41-50. doi: 10.1111/j.1460-9568.2008.06314.x.

PMID:
18662333
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk